Merck | MRK - Gross Profit On Sales

Stock Price
113.00
Daily Change
5.65 5.26%
Monthly
4.97%
Yearly
1.89%
Q2 Forecast
106.58

Merck reported EUR2.96B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Adidas EUR 3.09B 347M Dec/2025
Adyen EUR 1.08B 788.66M Dec/2024
Akzo Nobel EUR 1.04B 10M Jun/2025
Alcon AG USD 1.52B 58M Dec/2025
Amadeus IT EUR 980.6M 246.8M Dec/2025
Amarin USD 23.17M 961K Dec/2025
AstraZeneca USD 12.39B 5M Dec/2025
BASF EUR 3.11B 55M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
Covestro EUR 488M 64M Sep/2025
Danone EUR 6.82B 23M Dec/2024
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.39B 147M Dec/2025
Galapagos EUR -13.57M 74.82M Sep/2025
Genmab DKK 977M 13M Dec/2025
Givaudan CHF 1.55B 140M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Infineon EUR 1.46B 42M Dec/2025
Linde USD 3.27B 969M Dec/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 2.96B 252M Dec/2025
Novartis USD 10.25B 570M Dec/2025
Philips EUR 2.29B 377M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
UCB EUR 3.19B 621M Dec/2025